• By ICR Secretariat
  • Posted Thursday, March 11, 2021

Modified COVID-19 vaccines can avoid ‘lengthy’ clinical studies, says MHRA


Updated COVID-19 vaccines that are modified in response to new variants will not require a brand new approval or ‘lengthy’ clinical studies to receive authorisation, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced.